https://www.fiercebiotech.com/biotech/alnylam-scores-2b-from-blackstone-to-propel-pipeline-prospects
Alnylam scores $2B from Blackstone to propel pipeline prospects | Fierce Biotech
Apr 13, 2020 - With two approved drugs and a third on the way, Alnylam secured some much-needed capital to keep its RNAi pipeline rolling.
alnylamscoresblackstone
https://news.alnylam.com/
Newsroom | Alnylam
Welcome to Alnylam's newsroom where you can find the latest news, insights, perspectives and press releases.
newsroomalnylam
https://www.techtarget.com/pharmalifesciences/news/366607443/Rare-Disease-Drug-from-Alnylam-Gets-FDA-Approval
Rare Disease Drug from Alnylam Gets FDA Approval | TechTarget
FDA approves rare disease drug to be used in pediatric and adult patients with primary hyperoxaluria type 1, which causes recurrent kidney stones and loss of...
rare diseasefda approvaldrugalnylamgets
https://www.benzinga.com/news/earnings/23/02/31069825/alnylam-pharmaceuticalss-return-on-capital-employed-insights
Alnylam Pharmaceuticals's Return On Capital Employed Insights - Alnylam Pharmaceuticals...
alnylam pharmaceuticalsreturncapitalemployedinsights
https://www.arni-academie.fr/login-page/
Login page – Webinaire Alnylam
login pagewebinairealnylam
https://www.alnylam.de/
Alnylam® Pharmaceuticals | Deutschland | Alnylam-de
pharmaceuticalsdeutschlandalnylam
https://public.com/stocks/alny/after-hours
Trade Alnylam Pharmaceuticals (ALNY) Stock After-hours on Public.com
Trade Alnylam Pharmaceuticals (ALNY) stock after hours on Public.com from 4:00 pm to 8:00 pm ET. Track ALNY's after-hours price, range, and movement after the...
alnylam pharmaceuticalsafter hourson publictradestock
https://investors.alnylam.com/
Information and Resources for Investors | Alnylam
The Investor Relations website contains information about Alnylam Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial...
information and resourcesinvestorsalnylam
https://www.alnylamconnect.eu/
Therapeutic Areas | Alnylam Connect
Healthcare professionals only: Learn more about Alnylam's therapeutic areas by speaking with an Alnylam representative (by phone, email, video chat, or in...
therapeutic areasalnylamconnect
https://www.3blmedia.com/news/alnylam-issues-2021-corporate-responsibility-report
Alnylam Issues 2021 Corporate Responsibility Report
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today published its 2021 Corporate Responsibility Report.
corporate responsibilityalnylamissuesreport
https://jobs.alnylam.com/careers
Careers at Alnylam Pharmaceuticals
careers atalnylampharmaceuticals
https://alnylampolicies.com/
Alnylam Policies | Alnylam Policies
alnylampolicies
https://www.alnylam.com/
The Leading RNAi Therapeutics Company | Alnylam
Alnylam has pioneered RNAi therapeutics, an innovative approach to gene silencing. We are driven by science and committed to developing transformational...
leadingrnaitherapeuticscompanyalnylam
https://topworkplaces.com/company/alnylam-pharmaceuticals/boston/
Working at Alnylam Pharmaceuticals, Inc. | Top Workplaces
working at alnylampharmaceuticalsinctopworkplaces
https://www.biopharmadive.com/news/alnylam-helios-b-results-vutrisiran-ttr-cardiomyopathy/719580/
Alnylam says heart drug succeeds in closely watched study | BioPharma Dive
Positive results from a Phase 3 trial of vutrisiran in transthyretin amyloidosis cardiomyopathy set up a market competition with Pfizer and BridgeBio.
alnylamsaysheartdrugsucceeds
https://www.fool.com/earnings/call-transcripts/2020/02/06/alnylam-pharmaceuticals-inc-alny-q4-2019-earnings.aspx
Alnylam Pharmaceuticals Inc (ALNY) Q4 2019 Earnings Call Transcript | The Motley Fool
Feb 6, 2020 - ALNY earnings call for the period ending December 31, 2019.
earnings call transcriptalnylam pharmaceuticals
https://www.alnylam.it/
Home | Alnylam Italy
alnylamitaly
https://postesc11septembre2024.fr/
Invitation Alnylam
invitationalnylam
https://www.rnaiscience.com/
Alnylam Medical Information for US Healthcare Professionals | Alnylam RNAi Science - US
us healthcare professionalsmedical informationalnylamrnaiscience
https://alnylamassistcopay.com/
Alnylam Commercial Copay Enrollment
alnylamcommercialcopayenrollment
https://alnylamevents.com/
HomePage | Alnylam Events
homepagealnylamevents
https://aws.amazon.com/solutions/case-studies/alnylam-case-study/
Alnylam Transforms Product Complaint Management with Generative AI Using Amazon Bedrock
Learn how Alnylam Pharmaceuticals uses generative AI to enhance employee productivity and streamline product complaint management.
product complaintalnylamtransformsmanagement
https://www.oanda.com/eu-ro/trading/shares/us/alnylam-pharmaceuticals
Alnylam Pharmaceuticals Inc (ALNY) Trading | Shares / Shares CFDs | OANDA
Trade Alnylam Pharmaceuticals Inc (ALNY) shares CFDs with OANDA. View live charts and current market interest for this stock.
alnylam pharmaceuticalstrading sharesinccfdsoanda
https://www.foxbusiness.com/video/3053540734001
Alnylam president on $700M Genzyme deal | Fox Business Video
Biotech game changer?
fox businessalnylampresidentgenzymedeal
https://alnylam-medicalresearch.steeprockinc.com/
Alnylam Research Management System
research managementalnylamsystem
https://companiesmarketcap.com/alnylam-pharmaceuticals/cost-to-borrow/
Alnylam Pharmaceuticals (ALNY) - Cost to borrow
List of the companies with highest cost to borrow on Interactive Brokers. The cost to borrow is in annualized percents.
alnylam pharmaceuticalscostborrow
https://www.fool.ca/company/nasdaq-alny-alnylam-pharmaceuticals/336511/
Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price & News | The Motley Fool Canada
See the latest Alnylam Pharmaceuticals (NASDAQ:ALNY) stock price, company analysis, news, and price history from our investing experts.
the motley foolalnylam pharmaceuticalsstock pricenasdaq